Tumor promotion

Tumor promotion is a process in carcinogenesis by which various factors permit the descendants of a single initiated cell to survive and expand in number, i.e. to resist apoptosis and to undergo clonal growth. This is a step toward tumor progression.<ref>Seth Rakoff-Nahoum,

 Why Cancer and Inflammation?, 
 Yale Journal of Biology and Medicine, 
 
 Vol. 79(Issue: 3–4),
 pp. 123–130,
 
 PMID: 17940622,
 PMC: 1994795,</ref><ref>

NCI Dictionary of Cancer Terms:Tumor promotion(link). {{{website}}}. National Cancer Institute.

</ref>

In order for a tumor cell to survive, it must decrease its expression of tumor suppressor genes such as p53, BRCA1, BRCA2, RB1, or the fas receptor.<ref>

Tumor Suppressor Genes(link). {{{website}}}.

</ref><ref>

Oncogenes, Tumor Suppressor Genes, and Cancer(link). {{{website}}}. American Cancer Society.

</ref> A tumor suppressor would trigger an apoptotic pathway in a cancer cell if there were DNA damage, polyploidy, or uncontrolled cell growth.

Simultaneously, tumor cells need to upregulate oncogenes, which promote or cause downstream activation of growth factors and cell survival signals such as RAS,<ref>Cancer Genes: RAS</ref> Mitogen-activated protein kinase kinase, VEGF, or Akt.<ref>

Oncogenes, Tumor Suppressor Genes, and Cancer(link). {{{website}}}. American Cancer Society.

</ref>

See also

• Phorbol myristate acetate
• Tumor progression

References

<references />

   This article is a oncology stub. You can help WikiMD by expanding it!